EE9600183A - Kristalne (R)-(-)-2-{N-[4-(1,1-dioksido-3-okso-2,3-dihüdrobensisotiasool-2-üül) butüül ] aminometüül }kromaanhüdrokloriid, selle valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid - Google Patents
Kristalne (R)-(-)-2-{N-[4-(1,1-dioksido-3-okso-2,3-dihüdrobensisotiasool-2-üül) butüül ] aminometüül }kromaanhüdrokloriid, selle valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimidInfo
- Publication number
- EE9600183A EE9600183A EE9600183A EE9600183A EE9600183A EE 9600183 A EE9600183 A EE 9600183A EE 9600183 A EE9600183 A EE 9600183A EE 9600183 A EE9600183 A EE 9600183A EE 9600183 A EE9600183 A EE 9600183A
- Authority
- EE
- Estonia
- Prior art keywords
- dihydrobenzisothiazol
- dioxido
- aminomethyl
- medicaments
- medicines
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 2
- IGKYREHZJIHPML-UNTBIKODSA-N 2-[4-[[(2r)-3,4-dihydro-2h-chromen-2-yl]methylamino]butyl]-1,1-dioxo-1,2-benzothiazol-3-one;hydron;chloride Chemical compound Cl.O=S1(=O)C2=CC=CC=C2C(=O)N1CCCCNC[C@@H]1OC2=CC=CC=C2CC1 IGKYREHZJIHPML-UNTBIKODSA-N 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19543478A DE19543478A1 (de) | 1995-11-22 | 1995-11-22 | Kristallines Hydrochlorid von {(R)-(-)-2- N-[4-(1,1-Dioxido-3-oxo-2,3-dihydrobenzisothiazol-2-yl)-buytl]-aminomethyl}-chroman |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE9600183A true EE9600183A (et) | 1997-06-16 |
Family
ID=7778081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EE9600183A EE9600183A (et) | 1995-11-22 | 1996-11-21 | Kristalne (R)-(-)-2-{N-[4-(1,1-dioksido-3-okso-2,3-dihüdrobensisotiasool-2-üül) butüül ] aminometüül }kromaanhüdrokloriid, selle valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US5830908A (cs) |
| EP (1) | EP0775704B1 (cs) |
| JP (1) | JPH09143180A (cs) |
| KR (1) | KR970027079A (cs) |
| CN (1) | CN1086703C (cs) |
| AR (1) | AR004961A1 (cs) |
| AT (1) | ATE201872T1 (cs) |
| AU (1) | AU712922B2 (cs) |
| BR (1) | BR9605646A (cs) |
| CA (1) | CA2190700A1 (cs) |
| CZ (1) | CZ289730B6 (cs) |
| DE (2) | DE19543478A1 (cs) |
| DK (1) | DK0775704T3 (cs) |
| EE (1) | EE9600183A (cs) |
| ES (1) | ES2159342T3 (cs) |
| GR (1) | GR3036505T3 (cs) |
| HU (1) | HUP9603237A3 (cs) |
| IL (1) | IL119647A (cs) |
| MX (1) | MX9605741A (cs) |
| MY (1) | MY132473A (cs) |
| NO (1) | NO307340B1 (cs) |
| NZ (1) | NZ299780A (cs) |
| PL (1) | PL317090A1 (cs) |
| PT (1) | PT775704E (cs) |
| RU (1) | RU2181723C2 (cs) |
| SG (1) | SG44989A1 (cs) |
| SI (1) | SI0775704T1 (cs) |
| SK (1) | SK150096A3 (cs) |
| TR (1) | TR199600930A2 (cs) |
| TW (1) | TW449595B (cs) |
| UA (1) | UA45338C2 (cs) |
| ZA (1) | ZA969753B (cs) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5854217A (en) * | 1992-09-28 | 1998-12-29 | Bearsden Bio, Inc. | Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function |
| US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| US7501426B2 (en) | 2004-02-18 | 2009-03-10 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
| DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
| DE102005035891A1 (de) * | 2005-07-30 | 2007-02-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
| PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
| CN103951667A (zh) | 2006-05-04 | 2014-07-30 | 勃林格殷格翰国际有限公司 | 多晶型 |
| EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
| BRPI0815405A2 (pt) * | 2007-08-17 | 2015-02-03 | Boehringer Ingelheim Int | Compostos derivados de purina, processo para a preparação de uma composição farmacêutica e uso dos mesmos |
| PE20140960A1 (es) | 2008-04-03 | 2014-08-15 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
| PE20100156A1 (es) * | 2008-06-03 | 2010-02-23 | Boehringer Ingelheim Int | Tratamiento de nafld |
| UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
| KR20190016601A (ko) | 2008-08-06 | 2019-02-18 | 베링거 인겔하임 인터내셔날 게엠베하 | 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료 |
| JP5906086B2 (ja) * | 2008-08-15 | 2016-04-20 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｆａｂ関連疾患の治療に用いるためのプリン誘導体 |
| CA2736421A1 (en) | 2008-09-10 | 2010-03-18 | Boehringer Ingelheim International Gmbh | Combination therapy for the treatment of diabetes and related conditions |
| US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
| CA2745037C (en) | 2008-12-23 | 2020-06-23 | Boehringer Ingelheim International Gmbh | Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8(3-(r)-amino-piperidin-1-yl)-xanthine |
| AR074990A1 (es) | 2009-01-07 | 2011-03-02 | Boehringer Ingelheim Int | Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina |
| EA034869B1 (ru) | 2009-11-27 | 2020-03-31 | Бёрингер Ингельхайм Интернациональ Гмбх | Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин |
| CN102946875A (zh) | 2010-05-05 | 2013-02-27 | 贝林格尔.英格海姆国际有限公司 | 组合疗法 |
| ES2802243T3 (es) | 2010-06-24 | 2021-01-18 | Boehringer Ingelheim Int | Terapia para la diabetes |
| AR083878A1 (es) | 2010-11-15 | 2013-03-27 | Boehringer Ingelheim Int | Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento |
| MX366629B (es) | 2011-07-15 | 2019-07-17 | Boehringer Ingelheim Int | Quinazolinas sustituidas, su preparación y su uso en composiciones farmacéuticas. |
| US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
| ES2929025T3 (es) | 2012-05-14 | 2022-11-24 | Boehringer Ingelheim Int | Linagliptina, un derivado de xantina como inhibidor de dpp-4, para su uso en el tratamiento del SRIS y/o de la septicemia |
| US20130303462A1 (en) | 2012-05-14 | 2013-11-14 | Boehringer Ingelheim International Gmbh | Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome |
| WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
| EP3110449B1 (en) | 2014-02-28 | 2023-06-28 | Boehringer Ingelheim International GmbH | Medical use of a dpp-4 inhibitor |
| AU2017276758A1 (en) | 2016-06-10 | 2018-11-08 | Boehringer Ingelheim International Gmbh | Combinations of Linagliptin and metformin |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4748182A (en) * | 1986-03-05 | 1988-05-31 | Merrell Dow Pharmaceuticals Inc. | Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents |
| DE3901814A1 (de) | 1988-07-28 | 1990-02-01 | Bayer Ag | Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga |
| US5300523A (en) * | 1988-07-28 | 1994-04-05 | Bayer Aktiengesellschaft | Substituted aminomethyltetralins and their heterocyclic analogues |
| DE4138756A1 (de) * | 1991-11-26 | 1993-05-27 | Troponwerke Gmbh & Co Kg | Kombination mit neuroprotektiver wirkung |
-
1995
- 1995-11-22 DE DE19543478A patent/DE19543478A1/de not_active Withdrawn
-
1996
- 1996-10-30 AR ARP960104981A patent/AR004961A1/es unknown
- 1996-11-11 DE DE59607040T patent/DE59607040D1/de not_active Expired - Fee Related
- 1996-11-11 ES ES96118043T patent/ES2159342T3/es not_active Expired - Lifetime
- 1996-11-11 EP EP96118043A patent/EP0775704B1/de not_active Expired - Lifetime
- 1996-11-11 AT AT96118043T patent/ATE201872T1/de not_active IP Right Cessation
- 1996-11-11 PT PT96118043T patent/PT775704E/pt unknown
- 1996-11-11 SI SI9630292T patent/SI0775704T1/xx unknown
- 1996-11-11 DK DK96118043T patent/DK0775704T3/da active
- 1996-11-14 AU AU71772/96A patent/AU712922B2/en not_active Ceased
- 1996-11-18 JP JP8322212A patent/JPH09143180A/ja not_active Withdrawn
- 1996-11-19 CA CA002190700A patent/CA2190700A1/en not_active Abandoned
- 1996-11-19 IL IL11964796A patent/IL119647A/xx not_active IP Right Cessation
- 1996-11-19 US US08/752,348 patent/US5830908A/en not_active Expired - Fee Related
- 1996-11-19 NZ NZ299780A patent/NZ299780A/en unknown
- 1996-11-20 TW TW085114226A patent/TW449595B/zh not_active IP Right Cessation
- 1996-11-20 PL PL96317090A patent/PL317090A1/xx unknown
- 1996-11-20 SG SG1996011319A patent/SG44989A1/en unknown
- 1996-11-21 CZ CZ19963428A patent/CZ289730B6/cs not_active IP Right Cessation
- 1996-11-21 SK SK1500-96A patent/SK150096A3/sk unknown
- 1996-11-21 ZA ZA969753A patent/ZA969753B/xx unknown
- 1996-11-21 UA UA96114365A patent/UA45338C2/uk unknown
- 1996-11-21 NO NO964950A patent/NO307340B1/no not_active IP Right Cessation
- 1996-11-21 BR BR9605646A patent/BR9605646A/pt unknown
- 1996-11-21 EE EE9600183A patent/EE9600183A/xx unknown
- 1996-11-21 KR KR1019960056088A patent/KR970027079A/ko not_active Ceased
- 1996-11-21 MX MX9605741A patent/MX9605741A/es unknown
- 1996-11-21 MY MYPI96004849A patent/MY132473A/en unknown
- 1996-11-22 CN CN96114587A patent/CN1086703C/zh not_active Expired - Fee Related
- 1996-11-22 RU RU96122395/04A patent/RU2181723C2/ru active
- 1996-11-22 HU HU9603237A patent/HUP9603237A3/hu unknown
- 1996-11-22 TR TR96/00930A patent/TR199600930A2/xx unknown
-
2001
- 2001-08-31 GR GR20010401365T patent/GR3036505T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE9600183A (et) | Kristalne (R)-(-)-2-{N-[4-(1,1-dioksido-3-okso-2,3-dihüdrobensisotiasool-2-üül) butüül ] aminometüül }kromaanhüdrokloriid, selle valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid | |
| CY2008012I2 (el) | Υδροξυεστερες ραπαμυκινης, διαδικασια για τη παρασκευη τους και φαρμακευτικες συνθεσεις περιεχουσες αυτες | |
| EE03380B1 (et) | Farmatseutiline aerosoolpreparaat ja selle valmistamismeetod | |
| BR9504509A (pt) | Composto processo para sua preparaçao e formulaçao farmaceûtica | |
| NO972679L (no) | Fremgangsmåte for fremstilling av 1-(2'-deoksy-2',2'-difluor-D-ribofuranosyl-4-aminopyrimidin-2-on)hydroklorid | |
| EE9800437A (et) | N-[4-(heteroarüülmetüül)fenüül]-heteroarüülamiinid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja meetod selle valmistamiseks | |
| BR9503638A (pt) | Composto processo para sua produção e formulação farmacêutica | |
| FI940810L (fi) | Substituoidut bentseenisulfonyylivirtsa-aineet ja -tiovirtsa-aineet, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä | |
| EE03338B1 (et) | Tromboosivastane ravim, selle valmistamise protsess ja kasutamine | |
| CY2013003I1 (el) | Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων | |
| BR9004852A (pt) | Composto,processo para sua preparacao,sua aplicacao e composicao farmaceutica | |
| EE9600030A (et) | N-(3-bensofuranüül)karbamiidderivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks, nimetatud ühendeid sisaldavad ravimid ja nende valmistamismeetod | |
| BR9601275A (pt) | Compostos processo para sua preparação medicamentos preparação farmacêutica processo para sua produção e uso | |
| FI952550A7 (fi) | Uudet N-pyridyylikarboksamidit ja johdannaiset, menetelmät niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
| BR9506106A (pt) | Composto processo para sua preparação medicamento e composição farmacêutica | |
| EE04681B1 (et) | 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon | |
| BR9610316A (pt) | Composto processo para a produção e uso do mesmo processo para o tratamento de doença das vias aéreas e composição farmacêutica | |
| FI951631L (fi) | Substituoituja kynureniinejä, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä | |
| NO975076D0 (no) | Farmasöytisk preparat som inneholder tiagabinhydroklorid, og fremgangsmåte for dets fremstilling | |
| NO20001288D0 (no) | Substituerte 1,2,3,4,5,6-heksahydro-2,6-metano-3-benzazocin- 10-oler, fremgangsmÕte for fremstilling derav og anvendelse som legemiddel | |
| FI903818A7 (fi) | 1-(pyridinyyliamino)-2-pyrrolidoneja, menetelmä niiden valmistamiseksija niiden käyttö lääkkeinä | |
| BR9600778A (pt) | Benzenossulfoniluréia e - tiouréla substituida processo para sua preparação seu uso e medicamento | |
| NO953321D0 (no) | 2,3 cyklisk kondenserte 1,4-dihydropyridiner, fremgangsmåte for fremstilling derav og deres anvendelse som legemidler | |
| BR9600370A (pt) | Benzenossulfoniluréias e-tiouréias substituídas processo para a sua preparação seus usos e medicamento contendo as mesmas | |
| BR9506062A (pt) | Compostos processo para sua preparação medicamento e composição farmacêutica |